Los puntos clave no están disponibles para este artículo en este momento.
Chronic active lesions are common, are associated with more aggressive disease, exert ongoing tissue damage, and occur even in individuals treated with effective disease-modifying therapies. These results prompt the planning of MRI-based clinical trials aimed at treating perilesional chronic inflammation in MS.
Absinta et al. (Mon,) studied this question.